Advertisement
Canada markets close in 5 hours 12 minutes
  • S&P/TSX

    23,586.06
    -91.64 (-0.39%)
     
  • S&P 500

    5,637.60
    +3.02 (+0.05%)
     
  • DOW

    41,533.30
    -72.88 (-0.18%)
     
  • CAD/USD

    0.7356
    -0.0000 (-0.00%)
     
  • CRUDE OIL

    71.16
    -0.03 (-0.04%)
     
  • Bitcoin CAD

    81,162.57
    -677.48 (-0.83%)
     
  • XRP CAD

    0.77
    -0.03 (-3.78%)
     
  • GOLD FUTURES

    2,596.10
    +3.70 (+0.14%)
     
  • RUSSELL 2000

    2,202.68
    -2.80 (-0.13%)
     
  • 10-Yr Bond

    3.6930
    +0.0510 (+1.40%)
     
  • NASDAQ

    17,666.72
    +38.66 (+0.22%)
     
  • VOLATILITY

    19.07
    +1.46 (+8.29%)
     
  • FTSE

    8,254.60
    -55.26 (-0.67%)
     
  • NIKKEI 225

    36,380.17
    +176.95 (+0.49%)
     
  • CAD/EUR

    0.6615
    -0.0001 (-0.02%)
     

Why Novo Nordisk Stock Is Falling Today

Why Novo Nordisk Stock Is Falling Today

Shares of the Danish pharma giant Novo Nordisk (NYSE: NVO) were down by 3.4% on elevated volume as of 1:14 p.m. ET Tuesday afternoon. The drugmaker's shares are falling in response to the strong mid-stage data for Pfizer's orally administered diabetes and weight loss drug, danuglipron, which were published yesterday in JAMA Network medical journal. Novo's shares have more than doubled in value over the prior two years, thanks to the breakout success of its type 2 diabetes and weight loss drug semaglutide.